Tag: Clayton, Dubilier & Rice (CD&R)
McKesson, CD&R to buy Option Care for 37% premium
October 6, 2026HME News Staff
NEW YORK and IRVING, Texas – McKesson and CD&R will acquire Option Care Health for $32.05 per share, reflecting a total enterprise value of $5.8 billion. CD&R will hold a majority stake, and McKesson will hold a minority stake.
The transaction value represents a premium of about 37% to Option Care Health’s closing share price on Oct. 5, 2026, the last full trading day of the company’s common stock prior to the announcement.
In line with McKesson’s strategic objectives
The...
Elevance Health partners with PE firm for ‘whole health’ approach
April 15, 2024HME News Staff
INDIANAPOLIS – Health insurer Elevance Health and private equity firm Clayton, Dubilier & Rice have formed a strategic partnership to bring together certain care delivery and enablement assets of Elevance Health’s business unit Carelon Health and CD&R’s portfolio companies aspree health and Millenium Physician Group.
The companies say the strategic partnership’s advanced primary care models take a whole health approach to address the physical, social and behavioral...
CD&R closes deal on Drive
January 4, 2017HME News Staff
NEW YORK - Clayton, Dubilier & Rice has completed its equity investment in Drive DeVilbiss Healthcare, it announced Jan. 4. The deal allows Drive to continue its organic growth strategy, as well as provide the company with additional capital for future acquisitions. Drive has made 25 acquisitions since 2002, including the 2015 acquisition of DeVilbiss Healthcare. The deal was first announced in September. CD&R replaces Ferrer Freeman & Co., which has been a minority stockholder of Drive since 2008....
Drive taps into new investor
September 2, 2016Liz Beaulieu, Editor
PORT WASHINGTON, N.Y. - With a forthcoming “significant investment” from New York-based private equity firm Clayton, Dubilier & Rice, Drive DeVilbiss Healthcare is ready to double down on the HME industry, a company exec says.“Clearly, there is a lot of change in this industry, but it still presents tremendous opportunity for a company like ours,” Ed Link, chief marketing officer, told HME News.At closing, likely in the fourth quarter, CD&R will become a majority stockholder...